- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02871336
Pancreatic Surgical Database (CHIRPAN)
August 12, 2016 updated by: Institut Paoli-Calmettes
This data base has been set in order to gather medical and surgical information from patients who have undergone surgery for pancreatic cancer, at Institut Paoli Calmettes or Assistance Publique des Hôpitaux de Marseille, France.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bouches du Rhone
-
Marseille, Bouches du Rhone, France, 13009
- Recruiting
- Institut Paoli Calmettes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patient with a pancreatic cancer who has undergone surgery
Description
Inclusion Criteria:
- Patient >18 ans
- Surgery for a pancreatic cancer
Exclusion Criteria:
- Patient refusal to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optimization of the surgical care of the patients
Time Frame: 5 years
|
Collection of clinical and surgical data for future research studies
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Olivier Turrini, MD,PhD, Institut Paoli-Calmettes
- Principal Investigator: Vincent Moutardier, Assistance Publique Des Hopitaux de Marseille
- Principal Investigator: Jean HARDWIGSEN, Assistance Publique Des Hopitaux de Marseille
- Principal Investigator: Mehdi Ouassi, Assistance Publique Des Hopitaux de Marseille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Anticipated)
November 1, 2030
Study Registration Dates
First Submitted
August 3, 2016
First Submitted That Met QC Criteria
August 12, 2016
First Posted (Estimate)
August 18, 2016
Study Record Updates
Last Update Posted (Estimate)
August 18, 2016
Last Update Submitted That Met QC Criteria
August 12, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHIRPAN
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Neoplasms
-
Revolution Medicines, Inc.RecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Cancer Metastatic | Pancreatic Adenosquamous Carcinoma | Pancreatic Ductal Adenocarcinoma (PDAC) | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Pancreatic Adenocarcinoma MetastaticUnited States
-
Revolution Medicines, Inc.AvailablePancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Cancer Metastatic | Pancreatic Adenosquamous Carcinoma | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Pancreatic Adenocarcinoma Metastatic | Metastatic Pancreas Adenocarcinoma
-
Revolution Medicines, Inc.RecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Cancer Metastatic | Pancreatic Adenosquamous Carcinoma | Pancreatic Ductal Adenocarcinoma (PDAC) | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Pancreatic Adenocarcinoma MetastaticUnited States
-
City of Hope Medical CenterRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Resectable | Pancreatic Carcinoma | Pancreatic Cancer Non-resectable | Pancreatic Cancer Stage III | Pancreatic Cancer Stage | Pancreatic Cancer Stage II | Pancreatic Cancer, Adult | Pancreatic... and other conditionsUnited States, Japan, South Korea
-
Revolution Medicines, Inc.RecruitingPancreatic Cancer | Resected Pancreatic Adenocarcinoma | PDAC | PDAC - Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic Ductal Adenocarcinoma (PDAC)United States, Puerto Rico, United Kingdom
-
PanTher TherapeuticsRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic AdenocarcinomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CelgeneWithdrawnPancreatic Ductal Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
University of California, IrvineRecruitingPancreatic Cancer | Pancreatic Cancer MetastaticUnited States
-
Astellas Pharma Global Development, Inc.RecruitingPancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States, Japan
-
National Cancer Institute (NCI)Not yet recruitingStage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal Adenocarcinoma | Advanced Pancreatic Ductal Adenocarcinoma | Unresectable Pancreatic Ductal Adenocarcinoma
Clinical Trials on Data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
Hospices Civils de LyonCompleted
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingCerebrospinal; DisorderFrance
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance